IDEXX Laboratories Inc (BSP:I1DX34)
R$ 545.37 0 (0%) Market Cap: 224.44 Bil Enterprise Value: 228.24 Bil PE Ratio: 44.50 PB Ratio: 23.46 GF Score: 99/100

IDEXX Laboratories Inc at Stifel Dental & Veterinary Conference Transcript

May 29, 2019 / 05:15PM GMT
Jonathan David Block
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Equity Research Analyst

Okay, I see my mic's on, so we're going to go ahead and get started. Last animal health company for this afternoon just happens to be the #1 player in clinic in reference to that market, IDEXX Laboratories. I didn't used to be able to say #1 in a reference lab in the U.S., but I guess, now I certainly can.

With us from IDEXX, we have Brian McKeon, Executive Vice President and CFO; and Jay Mazelsky, Executive Vice President of the Companion Animal Group. As you guys have seen throughout the day, I've tried to structure this to hit on 4 or 5 main topics. You guys are a lot more important than me, so if you have any questions, just please raise your hand or go ahead and shout out. I want to start with utilization in the Preventative Care Challenge. I believe a big part of the top line growth strategy is driving utilization. Part of that is pursuing PCC or the Preventative Care Challenge as an initiative to drive utilization at the practice level. Jay, I'm going to turn to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot